Kenneth C. Anderson, MD

Kenneth C. Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School and director of the LeBow Institute for Myeloma Therapeutics and the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in Boston, MA. 

Over the last 4 decades, he has developed laboratory and animal models of multiple myeloma in its microenvironment, and this has allowed for both the identification of novel targets and the validation of novel targeted therapies. He has rapidly translated these studies to clinical trials, culminating in the US Food and Drug Administration approvals of novel targeted therapies, which have markedly improved patient outcomes. 

Dr Anderson has received the William Dameshek Prize from the American Society of Hematology, the AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research, the David A. Karnofsky Memorial Award and Lecture from the American Society of Clinical Oncology, and the Warren Alpert Foundation Prize from Harvard Medical School. He is a member of the National Academy of Medicine and past president of the International Myeloma Society and the American Society of Hematology.